THE COMPLETE PATHOMORPHOLOGICAL RESPONSE TO NEOADJUVANT THERAPY AND ITS ROLE IN THE TREATMENT STRATEGY FOR RECTAL CANCER

Cover Page

Cite item

Full Text

Abstract

The therapeutic strategy in rectal cancer has substantially changed in the past decade. Total mesorectumectomy has been widely used. Many specialized health facilities have accepted radio/chemoradiotherapy for locally advanced rectal cancer as a standard. At the same time as high as one quarter of the patients receiving neoadjuvant therapy demonstrate a complete pathomorphological regression of a tumor. In this connection, the current literature discusses whether medical treatment is permissible in this group of patients.

About the authors

A. M. Karachun

N.N. Petrov Research Institute of Oncology, Ministry of Health of Russia, Saint Petersburg;
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg

Author for correspondence.
Email: dr.a.karachun@gmail.com
Russian Federation

G. I. Sinenchenko

N.N. Petrov Research Institute of Oncology, Ministry of Health of Russia, Saint Petersburg;
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg

Email: dr.a.karachun@gmail.com
Russian Federation

D. V. Samsonov

N.N. Petrov Research Institute of Oncology, Ministry of Health of Russia, Saint Petersburg;
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg

Email: dr.a.karachun@gmail.com
Russian Federation

I. I. Aliyev

N.N. Petrov Research Institute of Oncology, Ministry of Health of Russia, Saint Petersburg;
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia, Saint Petersburg

Email: dr.a.karachun@gmail.com
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 85909 от  25.08.2023.